1. Home
  2. ATRA vs INLX Comparison

ATRA vs INLX Comparison

Compare ATRA & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • INLX
  • Stock Information
  • Founded
  • ATRA 2012
  • INLX 1996
  • Country
  • ATRA United States
  • INLX United States
  • Employees
  • ATRA N/A
  • INLX N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • INLX EDP Services
  • Sector
  • ATRA Health Care
  • INLX Technology
  • Exchange
  • ATRA Nasdaq
  • INLX Nasdaq
  • Market Cap
  • ATRA 51.1M
  • INLX 53.5M
  • IPO Year
  • ATRA 2014
  • INLX N/A
  • Fundamental
  • Price
  • ATRA $11.58
  • INLX $13.58
  • Analyst Decision
  • ATRA Strong Buy
  • INLX
  • Analyst Count
  • ATRA 4
  • INLX 0
  • Target Price
  • ATRA $20.00
  • INLX N/A
  • AVG Volume (30 Days)
  • ATRA 57.7K
  • INLX 2.2K
  • Earning Date
  • ATRA 08-11-2025
  • INLX 08-12-2025
  • Dividend Yield
  • ATRA N/A
  • INLX N/A
  • EPS Growth
  • ATRA N/A
  • INLX N/A
  • EPS
  • ATRA N/A
  • INLX N/A
  • Revenue
  • ATRA $199,732,000.00
  • INLX $17,758,634.00
  • Revenue This Year
  • ATRA N/A
  • INLX $7.58
  • Revenue Next Year
  • ATRA N/A
  • INLX N/A
  • P/E Ratio
  • ATRA N/A
  • INLX N/A
  • Revenue Growth
  • ATRA 475.53
  • INLX 3.21
  • 52 Week Low
  • ATRA $5.01
  • INLX $7.17
  • 52 Week High
  • ATRA $18.71
  • INLX $16.50
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 66.87
  • INLX 56.40
  • Support Level
  • ATRA $8.53
  • INLX $13.09
  • Resistance Level
  • ATRA $13.46
  • INLX $13.98
  • Average True Range (ATR)
  • ATRA 0.96
  • INLX 0.39
  • MACD
  • ATRA 0.28
  • INLX 0.06
  • Stochastic Oscillator
  • ATRA 62.65
  • INLX 52.63

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

Share on Social Networks: